Perspective Therapeutics, Inc. has entered into a $250 million Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co. and RBC Capital Markets, LLC, allowing it to sell shares of its common stock over time; it also terminated a previous sales agreement under which it sold 3,659,129 shares for $49.9 million.